Courts and states should be wary when an investigation risks commandeering the evidence needed to ascertain election results. That is where a largely forgotten Supreme Court case from the 1970s ...

The townspeople of Hope Valley are ready for more friendships, family and romance. “When Calls the Heart” officially returned for Season 13 on Jan. 4, nearly 10 months after viewers saw Elizabeth ...

If you’ve ever had a bad Windows update or a system corruption, you’ll know it can be paralyzing for your OS, or operating system and render it useless. That’s why you need to create a restore point ...

Vince Zampella, best known as the co-creator of the Call of Duty franchise and co-founder of Infinity Ward who went on to co-found Titanfall, Apex Legends, and Star Wars Jedi developer Respawn ...

If 2023 was the year of shock and 2024 was the year of experimentation, 2025 marks the moment the corporate world finally accepted that artificial intelligence is not just a novelty—it is the new ...

Ballad Health's Clinical Council leverages the expertise of physician leaders and frontline clinicians. The new CMO of Ballad Health's Johnson City Medical Center brings a wealth of experience to the ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. Before market open, ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

The congressional Democrats that President Donald Trump called seditious traitors hit back on Thursday and urged “every American” to “unite and condemn the President’s calls for our murder and ...

Just eight months after Gemini 2.5 launched, Google has upgraded its AI models once again with the release of Gemini 3. Gemini 3 officially began rolling out widely on November 18, and even this early ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...